Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 15, Pages 12132-12141
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2012-02-16
DOI
10.1074/jbc.m111.302299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mTOR Signaling in Cancer Cell Motility and Tumor Metastasis
- (2012) Hongyu Zhou et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor proliferation
- (2011) Ori Wald et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Rapamycin Inhibits Cytoskeleton Reorganization and Cell Motility by Suppressing RhoA Expression and Activity
- (2010) Lei Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer
- (2010) Guang Chen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- WJD008, a Dual Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin Inhibitor, Prevents PI3K Signaling and Inhibits the Proliferation of Transformed Cells with Oncogenic PI3K Mutant
- (2010) T. Li et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- PI3Kγ activation by CXCL12 regulates tumor cell adhesion and invasion
- (2009) María Monterrubio et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1 /CXCR4 Axis
- (2009) N. Song et al. CANCER RESEARCH
- Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway
- (2009) Yumei Wu et al. JOURNAL OF NEUROCHEMISTRY
- CXCR4 mediates the proliferation of glioblastoma progenitor cells
- (2008) Moneeb Ehtesham et al. CANCER LETTERS
- Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells
- (2008) Isaya Hashimoto et al. EUROPEAN JOURNAL OF CANCER
- Chemotherapy for metastatic gastric cancer in Japan
- (2008) Narikazu Boku International Journal of Clinical Oncology
- Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins
- (2008) L Liu et al. ONCOGENE
- The p110 isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110
- (2008) J. Guillermet-Guibert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started